Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Arena Pharmaceuticals Inc. (ARNA)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ARNA
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on ARNA
SA Editor Miriam Metzinger
(541 followers)
Jim Cramer's Mad Money Lightning Round Picks, Feb. 15
(Fri, Feb 16)
Jim Cramer's Mad Money In-Depth Stock Picks, Nov. 29
(Thu, Nov 30)
Jim Cramer's Mad Money Lightning Round Picks, Nov. 16
(Fri, Nov 17)
More by SA Editor Miriam Metzinger on ARNA »
Ruthanne Roussel
(75 followers)
Don't Expect Amylin to Eat the Obesity Market's Lunch
(Mon, Nov 2)
Why Orexigen's Empatic News Is Good
(Fri, Oct 2)
Two Positive Notes for Arena Pharmaceuticals
(Fri, Sep 18)
More by Ruthanne Roussel on ARNA »
Mike Havrilla
(1939 followers)
BioMed News Bytes: Arena, Momenta, Vivus
(Sun, Sep 20)
BioMed News Bytes: Arena, ImmunoCellular, YM Bio
(Fri, Sep 18)
Five Small-Cap Weight Loss Trades
(Wed, Jul 22)
More by Mike Havrilla on ARNA »
Most followed authors on ARNA
Philip Davis
(5899 followers)
Options Trader: Wednesday Outlook, Fed Edition
(Wed, Nov 4)
Options Trader Testy Tuesday Outlook: Dow 9,650, Berkshire $60 Edition
(Tue, Nov 3)
More by Philip Davis on ARNA »
Bespoke Investment Group
(3546 followers)
Companies With The Most Analyst Attention & Affection
(Tue, Jun 5)
More by Bespoke Investment Group on ARNA »
SA Editor Rachael Granby
(2022 followers)
Wall Street Breakfast: Must-Know News
(Tue, Aug 4)
More by SA Editor Rachael Granby on ARNA »
Newest authors on ARNA
Penn Bioinvestor
(59 followers)
Vivus: Obesity Experimental Drug Has Promising Outlook
(Wed, Jul 8)
More by Penn Bioinvestor on ARNA »
Beacon Asset Managers
(131 followers)
Arena's Edge in the Obesity Drug Race
(Sun, Jul 26)
More by Beacon Asset Managers on ARNA »
M. E. Garza
(522 followers)
6 Healthcare Stocks to Watch
(Tue, Jun 16)
Bio Medical Stock Sector is Where the Action Is
(Tue, Jun 9)
More by M. E. Garza on ARNA »
Most commented on ARNA
Ruthanne Roussel
(75 followers)
Don't Expect Amylin to Eat the Obesity Market's Lunch
(Mon, Nov 2)
Why Orexigen's Empatic News Is Good
(Fri, Oct 2)
Two Positive Notes for Arena Pharmaceuticals
(Fri, Sep 18)
More by Ruthanne Roussel on ARNA »
Michael Murphy
(528 followers)
Investing in the Obesity Drug Basket
(Mon, Sep 21)
A Biotech Triple Play: Dendreon, BioCryst and Arena
(Mon, May 25)
More by Michael Murphy on ARNA »
Derek Lowe
(132 followers)
Arena's Prospects Will Be in the Eye of the Suitors
(Sun, May 24)
Arena Pharma Could Be on the Verge of Collapse
(Mon, May 18)
Arena's Obesity Drug Not Likely to Make It
(Tue, Mar 31)
More by Derek Lowe on ARNA »